Smith & Nephew SNATS (SNN) Competitors $35.08 -0.64 (-1.78%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$35.10 +0.02 (+0.04%) As of 10/10/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, IRTC, BLCO, GKOS, and TMDXShould you be buying Smith & Nephew SNATS stock or one of its competitors? The main competitors of Smith & Nephew SNATS include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Smith & Nephew SNATS vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Solventum Penumbra Stevanato Group iRhythm Technologies Bausch + Lomb Glaukos TransMedics Group Smith & Nephew SNATS (NYSE:SNN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership. Is SNN or GEHC a better dividend stock? Smith & Nephew SNATS pays an annual dividend of $0.57 per share and has a dividend yield of 1.6%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays out 26.4% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years. Do institutionals and insiders hold more shares of SNN or GEHC? 25.6% of Smith & Nephew SNATS shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to SNN or GEHC? In the previous week, GE HealthCare Technologies had 25 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 28 mentions for GE HealthCare Technologies and 3 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 1.02 beat Smith & Nephew SNATS's score of 0.34 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GE HealthCare Technologies 18 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend SNN or GEHC? Smith & Nephew SNATS currently has a consensus target price of $36.00, indicating a potential upside of 2.61%. GE HealthCare Technologies has a consensus target price of $85.78, indicating a potential upside of 20.80%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts clearly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew SNATS 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00GE HealthCare Technologies 0 Sell rating(s) 5 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.55 Which has more risk & volatility, SNN or GEHC? Smith & Nephew SNATS has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Which has better valuation & earnings, SNN or GEHC? GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew SNATS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew SNATS$5.81B2.58$412M$2.1616.24GE HealthCare Technologies$19.67B1.65$1.99B$4.8814.55 Is SNN or GEHC more profitable? GE HealthCare Technologies has a net margin of 11.22% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 23.93% beat Smith & Nephew SNATS's return on equity.Company Net Margins Return on Equity Return on Assets Smith & Nephew SNATSN/A N/A N/A GE HealthCare Technologies 11.22%23.93%6.29% SummaryGE HealthCare Technologies beats Smith & Nephew SNATS on 15 of the 19 factors compared between the two stocks. Get Smith & Nephew SNATS News Delivered to You Automatically Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNN vs. The Competition Export to ExcelMetricSmith & Nephew SNATSMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$15.25B$10.76B$6.11B$21.89BDividend Yield1.60%1.88%5.67%3.61%P/E Ratio16.2420.2785.3528.80Price / Sales2.5830.81613.0683.44Price / Cash11.3225.5838.5024.17Price / Book2.913.3712.744.51Net Income$412M$208.83M$3.30B$1.01B7 Day Performance-3.46%-2.89%0.82%-3.52%1 Month Performance-8.92%-1.01%6.22%-1.94%1 Year Performance23.50%-6.90%80.30%10.27% Smith & Nephew SNATS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNNSmith & Nephew SNATS3.181 of 5 stars$35.09-1.8%$36.00+2.6%+22.9%$15.25B$5.81B16.2417,349Analyst ForecastGEHCGE HealthCare Technologies4.1771 of 5 stars$76.41-0.2%$86.89+13.7%-21.3%$34.95B$19.67B15.6653,000News CoveragePositive NewsAnalyst DowngradePHGKoninklijke Philips3.2049 of 5 stars$28.04+0.1%N/A-14.0%$26.96B$19.50B147.5866,678Analyst ForecastZBHZimmer Biomet4.7534 of 5 stars$98.88-1.9%$112.44+13.7%-7.8%$19.96B$7.68B24.0617,000Analyst ForecastSOLVSolventum2.9176 of 5 stars$73.88-0.2%$84.60+14.5%+3.6%$12.83B$8.25B34.2022,000News CoverageAnalyst ForecastPENPenumbra4.4357 of 5 stars$255.35-0.3%$302.93+18.6%+35.5%$9.99B$1.19B67.914,500Analyst ForecastSTVNStevanato Group1.6501 of 5 stars€24.57-5.4%N/A+30.2%€7.44B€1.19B45.505,521News CoverageAnalyst ForecastIRTCiRhythm Technologies1.1233 of 5 stars$175.74+0.1%$172.17-2.0%+207.1%$5.64B$591.84M-59.982,000Analyst ForecastBLCOBausch + Lomb1.9605 of 5 stars$14.87-2.2%$15.60+4.9%-25.0%$5.38B$4.79B-19.0613,500Analyst ForecastGKOSGlaukos4.2927 of 5 stars$86.64-0.9%$122.00+40.8%-35.6%$5.01B$383.48M-52.51780Analyst ForecastTMDXTransMedics Group3.2967 of 5 stars$113.93-1.5%$125.40+10.1%-21.1%$3.94B$441.54M59.03210Positive NewsAnalyst Forecast Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Zimmer Biomet Competitors Solventum Competitors Penumbra Competitors Stevanato Group Competitors iRhythm Technologies Competitors Bausch + Lomb Competitors Glaukos Competitors TransMedics Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SNN) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew SNATS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smith & Nephew SNATS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
